Targeted Alpha-Particle Therapy: A Review of Current Trials

Radiopharmaceuticals are rapidly developing as a field, with the successful use of targeted beta emitters in neuroendocrine tumors and prostate cancer serving as catalysts. Targeted alpha emitters are in current development for several potential oncologic indications. Herein, we review the three mos...

Descripción completa

Detalles Bibliográficos
Autores principales: Jang, Albert, Kendi, Ayse T., Johnson, Geoffrey B., Halfdanarson, Thorvardur R., Sartor, Oliver
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380274/
https://www.ncbi.nlm.nih.gov/pubmed/37511386
http://dx.doi.org/10.3390/ijms241411626

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380274/
https://www.ncbi.nlm.nih.gov/pubmed/37511386
http://dx.doi.org/10.3390/ijms241411626

Ejemplares similares